Jean-Briac Lesne started his professional career in the Life Sciences Venture Capital team of Omnes Capital.
Afterwards, he worked for Hyperion CD, an M&A and licensing advisory company dedicated to life sciences industries. In early 2015, he joined the management team of Inserm Transfert Initiative as analyst.
Jean-Briac holds a Pharm.D. from Rennes University and graduated from ESCP-Europe Business School.